Zenith Capital Corp.
$0.10-16.67%($-0.02)
TickerSpark Score
57/100
50
Valuation
40
Profitability
60
Growth
36
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZHCLF research report →
52-Week Range53% of range
Low $0.00
Current $0.10
High $0.19
Companywww.zenithepigenetics.com
Zenith Capital Corp. is a biotechnology investment company, which engages in the discovery and development of novel therapeutics. The company was founded by Donald J.
- CEO
- Donald J. McCaffrey
- IPO
- 2021
- HQ
- Calgary, AB, CA
Price Chart
+99900.00% · this period
Valuation
- Market Cap
- $15.97M
- P/E
- -3.03
- P/S
- 31.95
- P/B
- 0.00
- EV/EBITDA
- -5.50
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- -606.00%
- Net Margin
- -1050.00%
- ROE
- 0.00%
- ROIC
- 0.00%
Growth & Income
- Revenue
- $500.00K · 0.00%
- Net Income
- $-7,349,000 · 30.64%
- EPS
- $-0.05 · 31.19%
- Op Income
- $-4,792,000
- FCF YoY
- 100.00%
Performance & Tape
- 52W High
- $0.19
- 52W Low
- $0.00
- 50D MA
- $0.10
- 200D MA
- $0.07
- Beta
- -161.71
- Avg Volume
- 11.61K
Get TickerSpark's AI analysis on ZHCLF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ZHCLF Coverage
We haven't published any research on ZHCLF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ZHCLF Report →